Reagents & Consumables Segment to Lead Global dPCR and qPCR Market During 2022–2030 

According to our new research study on “dPCR and qPCR Market Forecast To 2030 – Global Analysis – by Treatment, Product, Application, and End User,” the dPCR and qPCR market is expected to grow from US$ 8,976.99 million in 2022 to US$ 18,230.74 million by 2030; it is estimated to record a CAGR of 9.3% from 2022–2030. Key factors driving the dPCR and qPCR market growth are the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.
 
The dPCR and qPCR market, by product, is segmented into reagents & consumables, instruments, and software & services. In 2022, the reagents & consumables segment held the largest share of the market and is anticipated to register the highest CAGR in the dPCR and qPCR market during the forecast period. The reagents & consumables segment is the most promising segment of the dPCR and qPCR market and contributes to tremendous growth during the forecast period. Reagents and consumables are essential parts of the dPCR and qPCR procedures. It includes buffers, probes, enzymes, dyes, vials, kits, panels, and others. Also, there are several kits available for gene expression analysis, SNP genotyping analysis, microRNA analysis, and others. The growing demand for earlier detection of disease, widespread use of consumables and reagents, and expanding demand for PCRs for healthcare, research, and other purposes have significantly fueled the growth of the segment.

The reagents and consumables market is characterized by the presence of a large number of manufacturers such as Thermo Fisher Scientific, Kaneka Eurogentec S.A., and QIAGEN. Moreover, developments, frequent product launches, rising acceptance of technology innovations, and increasing availability of the products are among the significant factors contributing to the growth of the segment. For instance, in July 2023, QIAGEN launched the CGT Viral Vector Lysis kit for the biopharmaceutical industry, expanding its range of dPCR kits and services. Therefore, these factors fuel the reagents & consumables segment of the dPCR and qPCR market to grow significantly in the near future.

Abbott Laboratories, Thermo Fisher Scientific Inc., Takara Bio Inc., Qiagen NV, Standard Biotools Inc., Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-la Roche Ltd, Bio-rad Laboratories Inc, Agilent Technologies Inc, and Genome Diagnostics Pvt Ltd are among the leading companies operating in the dPCR and qPCR market. 
 
Based on treatment, the dPCR and qPCR market is bifurcated into quantitative PCR and digital PCR. In terms of product, the dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In terms of end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. By geography, the dPCR and qPCR market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com